scispace - formally typeset
I

Isabelle Parrot

Researcher at University of Montpellier

Publications -  20
Citations -  440

Isabelle Parrot is an academic researcher from University of Montpellier. The author has contributed to research in topics: Protein–protein interaction & Peptide sequence. The author has an hindex of 8, co-authored 19 publications receiving 367 citations.

Papers
More filters
Journal ArticleDOI

Isoxazolidine: A Privileged Scaffold for Organic and Medicinal Chemistry

TL;DR: This review aims to be a comprehensive and general summary of the different isoxazolidine syntheses, their use as starting building blocks for the preparation of natural compounds, and their main biological activities.
Journal ArticleDOI

Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.

TL;DR: The results identify the first set of drug-like compounds that functionally target the HIV-1 Nef SH3 binding surface and provide the basis for a powerful discovery process that should help to speed up 2P2I strategies and open avenues for new class of antiviral molecules.
Journal ArticleDOI

Transannular rearrangement of activated 2,5-diketopiperazines: a key route to original scaffolds.

TL;DR: This powerful ring contraction allows for example the one-step synthesis of various tetramic acids, access to 2-disubstituted statins, or the synthesis of relevant lactam-constrained dipeptide mimetics using a TRAL-RCM sequence.
Journal ArticleDOI

Key Insights, Tools, and Future Prospects on Oyster Shell End-of-Life: A Critical Analysis of Sustainable Solutions.

TL;DR: This review constitutes the first critical compilation on oyster shell applications, with the aim to provide essential elements to better comprehend the recycling of waste oyster shells.
Journal ArticleDOI

Stereoselective ring contraction of 2,5-diketopiperazines: An innovative approach to the synthesis of promising bioactive 5-membered scaffolds.

TL;DR: Ring contraction of 2,5-diketopiperazines by TRAL-alkylation led to the stereoselective synthesis of original pyrrolidine-2,4-diones, a novel series of promising molecules with moderate anti-proliferative activity on breast cancer cells.